Rabeprazole 20 mg + Domperidone 30 mg(Sustained Release)
| Composition | Rabeprazole 20 mg + Domperidone 30 mg(Sustained Release) |
|---|---|
| Packing | 20x10 Alu/Alu |
| MRP | ₹ 2500 |
| Dosage Form | Capsules |
Rabzia-DSR Capsule contains Rabeprazole 20 mg and Domperidone 30 mg (Sustained Release), providing dual-action relief for acid reflux and associated gastric motility problems. Rabeprazole rapidly suppresses excess stomach acid, while the sustained-release Domperidone component is released gradually to provide prolonged improvement in gastric movement throughout the day.
This combination is particularly well suited for patients who experience heartburn along with symptoms of delayed gastric emptying such as nausea, bloating, and regurgitation. The sustained-release formulation of Domperidone ensures a smoother, longer-lasting prokinetic effect with a single daily dose.
This medicine is commonly used for:
Rabeprazole 20 mg + Domperidone 30 mg SR is indicated for the management of gastroesophageal reflux disease with concurrent gastric motility impairment, functional dyspepsia associated with hypersecretion and delayed gastric emptying, and symptomatic relief of nausea and regurgitation in gastroparesis. The sustained-release Domperidone formulation maintains therapeutic plasma concentrations for extended gastric motility support.
Rabzia-DSR works on two fronts: Rabeprazole quickly switches off the stomach's acid-producing pumps, reducing acid and allowing the esophagus and stomach lining to heal. The sustained-release Domperidone helps food travel through the stomach and intestines at a healthy pace, easing nausea, bloating, and the uncomfortable feeling of a full stomach long after eating.
Rabeprazole is a second-generation proton pump inhibitor that activates at a lower pH than earlier PPIs, allowing faster and more complete inhibition of the H+/K+ ATPase enzyme in gastric parietal cells with less interindividual variability due to CYP2C19 polymorphism. Domperidone (SR) is a peripheral dopamine D2 receptor antagonist that enhances antroduodenal peristalsis, increases lower esophageal sphincter pressure, and accelerates gastric emptying; the sustained-release formulation extends therapeutic plasma levels over 24 hours, reducing peak-related side effects.
Rabeprazole is unique among proton pump inhibitors because its activation is less dependent on the CYP2C19 liver enzyme, meaning its acid-suppressing effect is more consistent across patients regardless of their genetic metabolism type.
Rabzia-DSR is generally taken once daily before a meal, as prescribed by your doctor. The sustained-release formulation is designed to work throughout the day, so follow your doctor's dosage instructions carefully and do not crush or chew the capsule.
Always follow the dosage and schedule advised by your doctor — this is general guidance only.
Most people tolerate Rabzia-DSR well. Possible mild side effects include headache, diarrhea, dry mouth, or stomach discomfort. Domperidone may rarely affect heart rhythm. Tell your doctor if any side effect is severe or persistent.
Sustained-release medicines are just marketing — they work the same as regular tablets.
Sustained-release technology genuinely controls the rate at which a drug is released into the bloodstream, resulting in steadier drug levels, fewer peaks that can cause side effects, and a longer duration of action — all real clinical benefits.
Domperidone can make you sleepy because it acts on the brain.
Domperidone is specifically designed to act on gut nerves without significantly crossing the blood-brain barrier, which is why it improves stomach motility without commonly causing the sedation seen with older anti-nausea medicines.
Vitamin E 400 IU + Wheat germ Oil 100 mg + Omega 3 Fatty Acids 30 mg
Calcitrol IP 0.25 mcg + omega-3-fatty-acids containing Eicosapentaenoic acid 180 mg + Docosahexaenoic acid 120 mg + Folic acid 400 mcg + Methylcobalamine IP 1500 mcg + Boron 1.5 mg + calcium carbonate 500 mg
Rabeprazole 20 mg + Domperidone 30 mg(Sustained Release)
Omega 3 Fatty Acids Providing Eicosapentaenoic acid 90mg + Docosahexaenoic acid 60 mg + L-Methylfolate 1 mg + Vit K27 45 mcg + Methylcobalamine 1500 mcg, Pyridoxal-5-Phosphate 0.5 mg + Lycopene (6%) USP 10000mcg, Calcium Citrate USP 500 mg + Calcitriol IP 0.25 mcg, Magnesium Sulphate IP 50 mg